Ocriplasmin
Products Ocriplasmin is commercially available as an injectable (Jetrea). It has been approved in many countries since 2014. Structure and properties Ocriplasmin is a recombinant and truncated derivative of the human proteolytic enzyme plasmin with a molecular weight of 27.2 kDa. It is produced by biotechnological methods. Effects Ocriplasmin (ATC S01XA22) has proteolytic properties on … Ocriplasmin